Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Baumert

Showing results (21-30 of 385) with videos related to

Pageof 39
Sort By:
Ebiomedicine|August 11, 2019
Uncovering the mechanism of action of aspirin in HCC chemopreventionNatascha Roehlen, Thomas F Baumert
Hepatology International|June 27, 2023
Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis BSuzanne Faure-Dupuy, Thomas F Baumert
Journal of Hepatology|July 16, 2013
Hepatitis C virus co-opts innate immunity component for lipid droplet formationDaniel J Felmlee, Thomas F Baumert
Soins; La Revue De Reference Infirmiere|January 14, 2014
[Research on hepatitis c and therapeutic options]Mirjam B Zeisel, Thomas F Baumert
Expert Review of Clinical Pharmacology|June 28, 2016
Hepatitis B virus: is a cure possible?Mirjam B Zeisel, Thomas F Baumert
Future Microbiology|June 5, 2009
HCV entry and neutralizing antibodies: lessons from viral variantsMirjam B Zeisel, Thomas F Baumert
Gastroenterology|November 28, 2016
SMAD About Hepatitis C Virus Cell Entry and Liver DiseaseChe C Colpitts, Thomas F Baumert
Lancet (London, England)|January 15, 2017
Clinical development of hepatitis C virus host-targeting agentsMirjam B Zeisel, Thomas F Baumert
Nature Reviews. Gastroenterology & Hepatology|October 7, 2015
Viral hepatitis: A new HCV cell culture model for the next clinical challengesChe C Colpitts, Thomas F Baumert
Viruses|August 19, 2016
Addressing the Challenges of Hepatitis C Virus Resistance and Treatment FailureChe C Colpitts, Thomas F Baumert
Pageof 39

Showing results (21-30 of 385) with videos related to

Sort By:
Pageof 39
Ebiomedicine|August 11, 2019
Uncovering the mechanism of action of aspirin in HCC chemopreventionNatascha Roehlen, Thomas F Baumert
Hepatology International|June 27, 2023
Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis BSuzanne Faure-Dupuy, Thomas F Baumert
Journal of Hepatology|July 16, 2013
Hepatitis C virus co-opts innate immunity component for lipid droplet formationDaniel J Felmlee, Thomas F Baumert
Soins; La Revue De Reference Infirmiere|January 14, 2014
[Research on hepatitis c and therapeutic options]Mirjam B Zeisel, Thomas F Baumert
Expert Review of Clinical Pharmacology|June 28, 2016
Hepatitis B virus: is a cure possible?Mirjam B Zeisel, Thomas F Baumert
Future Microbiology|June 5, 2009
HCV entry and neutralizing antibodies: lessons from viral variantsMirjam B Zeisel, Thomas F Baumert
Gastroenterology|November 28, 2016
SMAD About Hepatitis C Virus Cell Entry and Liver DiseaseChe C Colpitts, Thomas F Baumert
Lancet (London, England)|January 15, 2017
Clinical development of hepatitis C virus host-targeting agentsMirjam B Zeisel, Thomas F Baumert
Nature Reviews. Gastroenterology & Hepatology|October 7, 2015
Viral hepatitis: A new HCV cell culture model for the next clinical challengesChe C Colpitts, Thomas F Baumert
Viruses|August 19, 2016
Addressing the Challenges of Hepatitis C Virus Resistance and Treatment FailureChe C Colpitts, Thomas F Baumert
Pageof 39